On the 17th of November, Dr Charles Steward, Patient Advocacy and Engagement Lead, spoke at the Progress Educational Trust (PET) event:

“Whole Genome Sequencing at Birth: What Should Be Looked For? What Should Be Fed Back?”.

The event was chaired by PET’s director, Sarah Norcross and included:

  • Dr Richard Scott, Chief Medical Officer at Genomics England and Consultant in Clinical Genetics at Great Ormond Street Hospital for Children
  • Professor Frances Flinter, an Emeritus Professor of Clinical Genetics at King's College London and trustee at PET
  • Dr Emma Baple, a Consultant in Clinical Genetics at the Royal Devon and Exeter Hospital and a member of the Newborn Genomes Programme's NHS Steering Group.

 

The panel discussed the Newborn Genomes Programme, which will examine the practical, ethical and societal questions raised by the possibility of expanding the current newborn screening programme in the UK, which currently tests for just nine conditions.

 

Read the write up of this event as it appeared in BioNews

 

To watch an interview of Dr Steward with PET’s director, Sarah Norcross, see the video below.

 

 

Find out more about the Progress Educational Trust (PET)

 

Keep up to date with the work of  Dr Charles Steward and Congenica's Patient Advocacy and Engagement team by signing up for our PAE newsletter

 

KEEP UP TO DATE WITH OUR PATIENT ADVOCACY NEWS 

Share